Skip to main content
Sections
Sections
Sections
Trade War
BNN Bloomberg App
TSX
S&P 500
DOW
Investing
Watch
Market Call
Shows
Search
Sign In
Search
Sign In
Download Our App
Trade War
Show Shows sub sections
Shows
Shows
The Street
The Open
Morning Markets
Market Call
Trading Day
The Close
Berman's Call
Know Your Options
Commodities
Taking Stock
Money Talk
Show Markets sub sections
Markets
Markets
TSX
Venture
S&P 500
NASDAQ
DOW
Currencies
Oil
Gold
Crypto
Show Investing sub sections
Investing
Investing
Market Outlook
Hot Picks
Investor Outlook
Commodities
Opinion
Cannabis
Personal Finance
ETFs
Show Video sub sections
Video
Video
Live
Investing
Company News
Real Estate
International
Economics
Artificial Intelligence
Technology
Personal Finance
Crypto
ETFs
Ticker Take
Company News
Economics
Big Six Banks Tracker
Real Estate
Politics
Artificial Intelligence
Technology
International
Newsletters
Podcasts
Press Releases
Team
CorpVOD
Advertise with BNN Bloomberg
Sponsored
CTVNews.ca
Opens in new window
CP24.com
Opens in new window
Share current article via Email
Share current article via X
Share current article via Reddit
Share current article via LinkedIn
Video
TempraMed targets $30B injectable market, expands to retail and insurance payors
Updated:
June 08, 2026 at 12:21PM EDT
Published:
June 08, 2026 at 12:22PM EDT
